1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Contraceptives Industry: Forecasts to 2025

  • September 2017
  • 189 pages
  • ID: 3999335
In this report:
This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.
Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.

Summary

Table of Contents

Global Contraceptives Market: Summary

The analysis on the contraceptive market examines the current and future scenario of the overall market. Growth in prevalence of unintended pregnancy, advent of additional low cost generics drugs and devices of contraceptives by key competitors, and rise in adoption and awareness for contraceptives usage in developing countries are the main drivers of the overall contraceptive market.

The contraceptive market report comprises a detailed executive summary, which comprises a market snapshot that offers data about several segments of the market. It also offers info and data analysis of the overall contraceptive market with respect to the segments established on product variety, distribution channel and territory. A in-depth qualitative analysis of drivers and restraints of the market and alternatives has been specified in the market survey part. Additionally, the section comprises five forces analysis and value chain study to comprehend the ambitious landscape in the sector. This section of the report also offers Analysis of market appeal, by area and market share review by top players, thus presenting a comprehensive study of the overall competitive scenario in the global contraceptive market.

Global Contraceptives Market: Market Segmentation

Established on product class, the contraceptive market is broken down as contraceptives drugs and contraceptive devices. The contraceptive drug is farther split into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is farther split into combined contraceptives and mini-pills. Contraceptive devices is broken down into male contraceptives and female contraceptives. Female contraceptive is split into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been examined based on available drugs and devices, product pipeline for additional contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market value and estimate for each of these segments have been provided for the time span from 2015 to 2025, together with their respective CAGRs for the outlook period from 2017 to 2025, considering 2016 as the base year.

Established on distribution channel, contraceptives market is divided into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been comprehensively studied based on availability of various contraceptive products, availability of these products at distinct distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each division have been provided for the time span from 2015 to 2025. The market research also offers the CAGR for each market segment for the estimate period from 2017 to 2025, considering 2016 as the base year.

Geographically, the overall contraceptive market has been classified into five main regions and the main countries in the respective region: North America continent, EU (the United Kingdom, Germany (DE), Russia, France (FR), Spain (ES), Italy (IT), and Rest of Europe (EU)), Asia-Pac (Japan (JP), India (IN), China (CN), Australia (AU) & New Zealand and Rest of Asia Pacific (APAC)), Latin America area (Brazil (BR), Mexico (MX), and Rest of Latin America area) and Middle East area & African continent (South Africa (ZA), GCC countries and Rest of Middle East (ME) & African continent). The market value and estimate for each of these regions and the mentioned countries have been provided for the time span from 2015 to 2025, together with their respective CAGRs for the outlook period from 2017 to 2025, considering 2016 as the base year. The business research study also includes the ambitious scenario in these areas.

Overall Contraceptives Market: Opposing landscape

The study also describes main actors in the overall contraceptive segment based on several features such as corporate overview and financial analysis, product portfolio, strategic management, and recent evolutions. Top actors decribed in this industry report includes Merck & Co., Incorporated, Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Incorporated, Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.

Global Contraceptive Market, by Geography

North America (NA)

US

Canada (CA)

Europe (EU)

Germany (DE)

United Kingdom (UK)

Russia (RU)

Italy (IT)

France (FR)

Spain (ES)

Rest of europe (EU)

Asia-Pac

Japan (JP)

India (IN)

China (CN)

Australia & New Zealand

Rest of Asia Pacific (APAC)

Latin America

Brazil (BR)

Mexico (MX)

Rest of Latin America

African region & Middle East

GCC countries

South africa (SA)

Rest of African region and Middle East

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Emergency Contraceptive Pill Market 2018-2022

Emergency Contraceptive Pill Sector: Worldwide Forecast until 2022

  • $ 2491
  • Industry report
  • July 2018
  • by Infiniti Research Limited

About Emergency Contraceptive PillAn emergency contraceptive pill is a short-term method of contraception that needs to be consumed within 72 hours of unprotected sexual intercourse, sexual assault, lapse ...

Female Contraception R&D Pipeline Analysis Report, H2-2018

Female Contraception R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • Industry report
  • August 2018
  • by VPAResearch

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studiesFemale Contraception Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information ...

Male Contraception Ongoing Global Clinical Trials Analysis and Outlook

Male Contraception Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • Industry report
  • June 2018
  • by VPAResearch

Male Contraception ongoing clinical trials report provides comprehensive analysis and trends in global Male Contraception disease clinical trials. The research work analyzes the ongoing Male Contraception ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on